The chairman of Cambridge Therapeutics in Alpine, NJ, John Klein is an experienced executive in the pharmaceutical industry. In addition to providing strategic guidance to Cambridge Therapeutics, John Klein recently launched Bilogix, his newest business venture based in Alpine.
Bilogix is a firm focused on meeting the enterprise performance management (EPM) needs of today’s businesses. A form of business intelligence, EPM refers to the high-level analysis of a company’s performance with the goal of creating a strategic plan that is designed to optimize its overall performance. EPM can help an enterprise to increase its efficiency, streamline operations, and meet its performance and financial goals. In addition, EMP can enable a company to make better business decisions.
Also known as corporate performance management, EPM encompasses solutions such as benchmarking, analytics, scorecards, management dashboards, performance reporting, and budgeting and forecasting. The use of these techniques and tools can assist organizations seeking to improve their performance and ultimately boost profits.